Adesis, Inc. is a chemistry based contract research organization (CRO) focusing on the expedient synthesis of bioactive small molecules. Adesis, Inc. in collaboration with life science and biomaterials companies conducts projects for the discovery and synthesis of investigational bioactive molecules, molecular scaffolds, building blocks and advance intermediates and reference standards (competitor drugs and investigational agents).

The life science industry is rapidly adopting the practice of collaborating (or outsourcing) as an adjunct to maximize 1) project-specific technology applications, 2) “just-in-time” skill set needs, and 3) operational needs (maintain project focus, control R&D costs, human resources). Adesis, Inc. technical successes are based on its experienced chemists with diverse expertise in multi-step synthesis (typically 8-24 steps) of complex natural products, heterocycles, carbohydrates, peptides, peptidomimetics and new structural entities.